Tilray Inc buy Maxfloh
Summary
This prediction ended on 27.01.20 with a price of €17.50. Massive losses of -55.22% were the result for the BUY prediction by Maxfloh. Maxfloh has 50% into this predictionTilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Tilray Inc | -14.105% | -14.105% | -78.620% | - |
iShares Core DAX® | 1.665% | 1.692% | 18.093% | 15.353% |
iShares Nasdaq 100 | -0.475% | 1.483% | 27.860% | 36.314% |
iShares Nikkei 225® | 2.620% | 4.475% | 17.651% | 10.750% |
iShares S&P 500 | -0.091% | 1.099% | 24.873% | 36.740% |
Comments by Maxfloh for this prediction
In the thread Tilray Inc diskutieren
Maxfloh stimmt der Buy-Einschätzung von melinda zu
Maxfloh stimmt am 13.07.2019 der Buy-Einschätzung von melinda mit dem Kursziel 93$ zu.
Überschrift: SecteurProduits pharmaceutiques